Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

A comparison of sodium-glucose co-transporter 2 inhibitor kidney outcome trial participants with a real-world chronic kidney disease primary care population

Forbes AK. et al, (2025), Nephrology Dialysis Transplantation, 40, 71 - 82

Physical, cognitive, and social triggers of symptom fluctuations in people living with long COVID: an intensive longitudinal cohort study

Greenwood DC. et al, (2024), The Lancet Regional Health - Europe, 46

Phenotype execution and modeling architecture to support disease surveillance and real-world evidence studies: English sentinel network evaluation

Jamie G. et al, (2024), JAMIA Open, 7

Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series study

Tsang RSM. et al, (2024), Journal of the Royal Society of Medicine, 117, 134 - 148

AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study

Meeraus W. et al, (2024), Journal of Infection, 88

Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional study

Forbes AK. et al, (2024), eClinicalMedicine, 68

Hepatitis A vaccination coverage amongst people with Chronic Liver Disease in England (HEALD): protocol for a retrospective cohort study (Preprint)

Meza-Torres B. et al, (2023)

Hepatitis A vaccination coverage amongst people with Chronic Liver Disease in England (HEALD): protocol for a retrospective cohort study (Preprint)

Meza-Torres B. et al, (2023), JMIR Research Protocols

Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study

Tsang RSM. et al, (2023), Eurosurveillance, 28

Sodium-glucose cotransporter-2 inhibitors and kidney outcomes in real-world type 2 diabetes populations: A systematic review and meta-analysis of observational studies

Forbes AK. et al, (2023), Diabetes, Obesity and Metabolism

Barriers and Facilitators to the Initiation of Injectable Therapies for Type 2 Diabetes Mellitus: A Mixed Methods Study.

de Lusignan S. et al, (2022), Diabetes therapy : research, treatment and education of diabetes and related disorders

Mortality from angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers in people infected with COVID-19: a cohort study of 3.7 million people.

Dambha-Miller H. et al, (2022), Fam Pract

Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study).

Feher M. et al, (2022), JMIR Res Protoc, 11

Mortality in COVID-19 among women on hormone replacement therapy: a retrospective cohort study.

Dambha-Miller H. et al, (2022), Fam Pract

The Effect of the COVID-19 Pandemic on Glycemic Monitoring and Other Processes of Care for Type 2 Diabetes: Protocol for a Retrospective Cohort Study

Mathew M. et al, (2022), JMIR Research Protocols, 11

BMI and HbA1c are metabolic markers for pancreatic cancer: Matched case-control study using a UK primary care database

Lemanska A. et al, (2022), PloS one, 17

Early and ongoing stable glycaemic control is associated with a reduction in major adverse cardiovascular events in people with type 2 diabetes: A primary care cohort study

Whyte MB. et al, (2022), Diabetes, Obesity and Metabolism

Sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: Are clinical trial benefits for heart failure reflected in real-world clinical practice? A systematic review and meta-analysis of observational studies

Hinton W. et al, (2022), Diabetes, Obesity and Metabolism

Effect of COVID-19 pandemic on glycaemic monitoring and other processes of care in Type 2 Diabetes: Protocol for a retrospective cohort study (Preprint)

Mathew M. et al, (2021)

Fenofibrate as a COVID-19 modifying drug: Laboratory success versus real-world reality

Feher M. et al, (2021), Atherosclerosis, 339, 55 - 56

Load More